Fluidinova produces high quality hydroxyapatite nanoparticles (CAS n. 1306-06-5) as a raw-material for medical devices applications. The nanoXIM•HAp
products present high purity, single-phase, nanocrystalline features and are in compliance with the ISO13779 and ASTM F1185 standards requests for medical applications regarding heavy metals and other specifications.
High Resolution Transmission Electronic Microscopy (HRTEM) analysis reveals that nanoXIM•HAp
products are highly nanocrystalline, presenting the nanocrystals in a structure perfectly aligned.
Other main characteristics of the nanoXIM•HAp
material are the high specific surface BET area (> 100 m2
/g) and the precise stoichiometry of Calcium/Phosphate ions resulting in a Ca/P ratio always near to 1.67. The high consistency level of these materials results in a strongly feasible product for medical applications. ReferencesProduct Range
nanoXIM•HAp nanocrystalline hydroxyapatite
is distributed in the form of water based pastes
with solids content of 15% and 30% and spray-dried powders